NSPR · Company research
InspireMD, Inc. (NSPR): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| InspireMD (NSPR) Climbs 8.5% to $0.52 as Shares Reclaim the $0.50 Level - Butterfly Setup - https://www.siam.in/ | InspireMD (NSPR) Climbs 8.5% to $0.52 as Shares Reclaim the $0.50 Level - Butterfly Setup https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 10, 2026 | neutral | 0 | 0.6 |
| InspireMD (NSPR) Climbs 8.5% to $0.52 as Shares Reclaim the $0.50 Level - Momentum Trade - https://www.dars.gov.et/ | InspireMD (NSPR) Climbs 8.5% to $0.52 as Shares Reclaim the $0.50 Level - Momentum Trade https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 10, 2026 | neutral | 0 | 0.6 |
| An anticipated FDA approval could open up $11 million for InspireMD's stroke-prevention device. - Stock Titan | An anticipated FDA approval could open up $11 million for InspireMD's stroke-prevention device. Stock Titan | View source ↗ | Stock Titan | Sep 21, 2026 | neutral | 0 | 0.6 |
| InspireMD Inc. (NSPR) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research | InspireMD Inc. (NSPR) Financials – Balance Sheet, Profit & Loss, Cash Flow Value Research | View source ↗ | Value Research | Aug 27, 2026 | neutral | 0 | 0.6 |
| InspireMD Reports $1.77 Million Q2 Revenue and $14.32 Million Net Loss - Quiver Quantitative | InspireMD Reports $1.77 Million Q2 Revenue and $14.32 Million Net Loss Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 17, 2026 | neutral | 0 | 0.6 |
| InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance | InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Aug 14, 2026 | neutral | 0 | 0.6 |
| INSPIREMD Q2 2026 Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative | INSPIREMD Q2 2026 Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 14, 2026 | neutral | 0 | 0.6 |
| InspireMD Schedules 8:30 a.m. Call to Discuss Q2 Results - Stock Titan | InspireMD Schedules 8:30 a.m. Call to Discuss Q2 Results Stock Titan | View source ↗ | Stock Titan | Aug 10, 2026 | neutral | 0 | 0.6 |
| Insider Buyers At InspireMD Recover Some Losses, But Still Down US$161k - Simply Wall Street | Insider Buyers At InspireMD Recover Some Losses, But Still Down US$161k Simply Wall Street | View source ↗ | Simply Wall Street | Aug 8, 2026 | neutral | 0 | 0.6 |
| InspireMD Inc (NASDAQ: NSPR) Share Price, NSPR Stock News, NSPR Share Price & Updates - Kalkine | InspireMD Inc (NASDAQ: NSPR) Share Price, NSPR Stock News, NSPR Share Price & Updates Kalkine | View source ↗ | Kalkine | Aug 7, 2026 | neutral | 0 | 0.6 |
| InspireMD Eliminates Chief Commercial Officer Position - The Globe and Mail | InspireMD Eliminates Chief Commercial Officer Position The Globe and Mail | View source ↗ | The Globe and Mail | Jul 30, 2026 | neutral | 0 | 0.6 |
| NSPR Forecast — Price Target — Prediction for 2027 - TradingView | NSPR Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| NSPR Rallies After Hours On FDA Green Light for Key Stroke-Prevention Trial Despite Withdrawn Annual Guidance - Stocktwits | NSPR Rallies After Hours On FDA Green Light for Key Stroke-Prevention Trial Despite Withdrawn Annual Guidance Stocktwits | View source ↗ | Stocktwits | May 1, 2026 | neutral | 0 | 0.6 |
| After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR) - Yahoo Finance | After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR) Yahoo Finance | View source ↗ | Yahoo Finance | Apr 8, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 1, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.